Kaarteenaho R - Search Results

1

[Diagnostics of lung cancers becoming more precise].

Lappi-Blanco E, Mäkinen JM, Jartti A, Mali P, Kaarteenaho R. Lappi-Blanco E, et al. Among authors: kaarteenaho r. Duodecim. 2012;128(21):2225-35. Duodecim. 2012. PMID: 23210285 Review. Finnish.

2

Re-hospitalisation predicts poor prognosis after acute exacerbation of interstitial lung disease.

Salonen J, Jansa S, Vähänikkilä H, Kaarteenaho R. Salonen J, et al. Among authors: kaarteenaho r. BMC Pulm Med. 2023 Jul 1;23(1):236. doi: 10.1186/s12890-023-02534-0. BMC Pulm Med. 2023. PMID: 37393286 Free PMC article.

3

Virtual communication is commonly used in Finnish interstitial lung disease multidisciplinary meetings.

Salonen J, Nurmi H, Hodgson U, Hasala H, Kilpeläinen M, Hollmen M, Purokivi M, Kaarteenaho R. Salonen J, et al. Among authors: kaarteenaho r. Eur Clin Respir J. 2023 Mar 17;10(1):2190210. doi: 10.1080/20018525.2023.2190210. eCollection 2023. Eur Clin Respir J. 2023. PMID: 36950471 Free PMC article.

4

Treatment outcomes of non-small cell lung cancers treated with EGFR tyrosine kinase inhibitors: a real-world cohort study.

Manninen O, Puuniemi L, Iivanainen S, Arffman M, Kaarteenaho R, Koivunen JP. Manninen O, et al. Among authors: kaarteenaho r. Acta Oncol. 2023 Dec;62(12):1854-1861. doi: 10.1080/0284186X.2023.2274481. Epub 2023 Nov 25. Acta Oncol. 2023. PMID: 37934101 Free article.

5

Primary myocardial fibrosis - a distinct entity characterized by heterogeneous histology.

Pakanen L, Appel H, Ahtikoski A, Holm PH, Kreus M, Olsen KB, Banner J, Winkel BG, Huikuri H, Kaarteenaho R, Junttila J. Pakanen L, et al. Among authors: kaarteenaho r. Cardiovasc Pathol. 2023 Nov-Dec;67:107573. doi: 10.1016/j.carpath.2023.107573. Epub 2023 Sep 6. Cardiovasc Pathol. 2023. PMID: 37683738 Free article.

6

Comorbidities and Causes of Death of Patients With Asbestosis.

Keskitalo E, Salonen J, Nurmi H, Vähänikkilä H, Kaarteenaho R. Keskitalo E, et al. Among authors: kaarteenaho r. J Occup Environ Med. 2023 Apr 1;65(4):349-353. doi: 10.1097/JOM.0000000000002777. Epub 2022 Dec 23. J Occup Environ Med. 2023. PMID: 36728947

7

Contribution of collagen XIII to lung function and development of pulmonary fibrosis.

Norman O, Koivunen J, Kaarteenaho R, Salo AM, Mäki JM, Myllyharju J, Pihlajaniemi T, Heikkinen A. Norman O, et al. Among authors: kaarteenaho r. BMJ Open Respir Res. 2023 Dec 12;10(1):e001850. doi: 10.1136/bmjresp-2023-001850. BMJ Open Respir Res. 2023. PMID: 38568728 Free PMC article.

8

KIF15 missense variant is associated with the early onset of idiopathic pulmonary fibrosis.

Hollmén M, Laaka A, Partanen JJ, Koskela J, Sutinen E, Kaarteenaho R, Ainola M, Myllärniemi M. Hollmén M, et al. Among authors: kaarteenaho r. Respir Res. 2023 Sep 30;24(1):240. doi: 10.1186/s12931-023-02540-0. Respir Res. 2023. PMID: 37777755 Free PMC article.

9

National data on prevalence of idiopathic pulmonary fibrosis and antifibrotic drug use in Finnish specialised care.

Salonen J, Purokivi M, Hodgson U, Kaarteenaho R. Salonen J, et al. Among authors: kaarteenaho r. BMJ Open Respir Res. 2022 Sep;9(1):e001363. doi: 10.1136/bmjresp-2022-001363. BMJ Open Respir Res. 2022. PMID: 36571594 Free PMC article.

10

Novel patients with NHLRC2 variants expand the phenotypic spectrum of FINCA disease.

Tallgren A, Kager L, O'Grady G, Tuominen H, Körkkö J, Kuismin O, Feucht M, Wilson C, Behunova J, England E, Kurki MI, Palotie A, Hallman M, Kaarteenaho R, Laccone F, Boztug K, Hinttala R, Uusimaa J. Tallgren A, et al. Among authors: kaarteenaho r. Front Neurosci. 2023 Apr 27;17:1123327. doi: 10.3389/fnins.2023.1123327. eCollection 2023. Front Neurosci. 2023. PMID: 37179546 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters